TMOThermo Fisher Scientific

$633.95

$437.9052 weeks$638.18

Price

$633.95+42%1Y

1M+11%1Y+42%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

9/10

Value58

Quality85

Momentum62

Growth48

Strongest Quality, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. We serve customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings.

In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR

P/E (TTM)34.1

Market Cap$172.66B

1Y Return+42%

5Y Return+19%

Business segments

Q2 2026 · $2.78B

The company’s own SEC segment disclosure.

Life Sciences Solutions$1.06B38%
Analytical Instruments$821.0M30%
Laboratory Products And Biopharma Services$608.0M22%
Specialty Diagnostics$290.0M10%

Thermo Fisher Scientific (TMO) reported revenue of $12.0B in Q2 2026 (quarter ended June 27, 2026), up 10% from the same quarter a year earlier. That came with net income of $1.74B (14% of revenue). For the full year FY2025, revenue was $44.6B (+3.9% year on year) and net income $6.70B. Its largest segment in 2026-Q2 was Life Sciences Solutions at $1.06B, 38% of the disclosed total, just ahead of Analytical Instruments at 30%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Diagnostics & Research

Ranks #9 of 29 by Smart Score